MedTrace Logo

Topical Treatment and Prevalence of P. Acnes

NCT03257202 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-11-13

Study results available
· View outcomes & findings →

Summary

This study is about preventing surgical site infections of the shoulder. We hope to learn if clindamycin alone, benzoyl peroxide alone, or clindamycin and benzoyl peroxide together can affect growth of Propionibacterium acnes in the dermal layer.

Conditions

  • Surgical Site Infection

Interventions

DRUG

Clindamycin 1% Gel

topical clindamycin

DRUG

Benzoyl peroxide 5% gel

topical benzoyl peroxide

DRUG

BenzaClin 5%-1% Topical Gel

Topical clindamycin and benzoyl peroxide together

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • George R Hatch, MD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-11
Primary Completion
2018-01-01
Completion
2018-01-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03257202 on ClinicalTrials.gov